Cancer Genetics Inc (NASDAQ:CGIX)

9.87
Delayed Data
As of Jul 27
 0.00 / 0.00%
Today’s Change
4.83
Today|||52-Week Range
12.75
+47.75%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Cancer Genetics Inc have a median target of 15.38, with a high estimate of 15.80 and a low estimate of 13.00. The median estimate represents a +55.78% increase from the last price of 9.87.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Cancer Genetics Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.49
Sales
$4.6M
Reporting Date
Aug 13

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -10.80%
 
 
 
 
 
 
Growthannually -9.94%
 
 
 
 
 

Sales

Growthquarterly 4.67%
 
 
 
 
 
 
Growthannually 105.77%
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account